Ashwagandha sits on supplement shelves between multivitamins and protein powder, but its biological activity has more in common with prescription anxiolytics and hormone-modulating drugs than with most products in that aisle. The root extract directly activates GABA receptors in the brain, measurably shifts thyroid hormone and testosterone levels, and has triggered liver injury serious enough to land people in the hospital. That pharmacological profile, documented across dozens of clinical trials and case reports, is what makes ashwagandha genuinely useful for some people and genuinely risky for others.
How It Talks to Your Brain
The most drug-like thing ashwagandha does is activate GABA receptors, the same receptor family targeted by benzodiazepines like diazepam and sleep aids like zolpidem. Lab research on mammalian brain receptors found that an aqueous extract of ashwagandha directly opened GABA-A ion channels in a dose-dependent manner, and those currents were blocked by bicuculline, the standard GABA-A antagonist. Interestingly, the two best-known individual compounds in ashwagandha, withanone A and withanolide A, did not activate these receptors on their own, suggesting that some other constituent or combination in the whole extract is responsible for the effect.1PubMed. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors
Animal studies have extended this finding. Mice given an amylase-treated ashwagandha extract showed increased GABA content in the brain along with higher expression of both GABA-A and GABA-B receptors, as well as serotonin receptors. The extract promoted sleep through this GABAergic system, binding to multiple GABA-A receptor sites.2PubMed Central. Sleep-promoting activity of amylase-treated Ashwagandha (Withania somnifera L. Dunal) root extract via GABA receptors This is not a vague “calming” effect. It is a specific, receptor-level mechanism shared with some of the most widely prescribed sedative and anti-anxiety medications in modern medicine.
Ashwagandha also appears to dampen the body’s stress-response machinery at a higher level. In stressed adults, supplementation reduced morning cortisol and DHEA-S, markers of hypothalamic-pituitary-adrenal (HPA) axis activity. The interpretation is that the herb makes the stress-response system less reactive to stressors, essentially dialing down the alarm volume rather than eliminating the alarm.3PubMed Central. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract
What the Clinical Trials Show for Stress and Sleep
The stress-reduction data in humans is among the strongest in the herbal supplement world. A randomized, double-blind, placebo-controlled trial of a high-concentration root extract found dramatic reductions in self-reported depression, anxiety, and stress scores after 60 days. The ashwagandha group saw roughly a 76% reduction in depression scores, a 76% reduction in anxiety scores, and a 64% reduction in stress scores. The placebo group barely moved, with changes of around 5% for depression, a slight increase in anxiety, and about 10% for stress.4PubMed Central. A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of a High-Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults Those are the kind of effect sizes you normally see with pharmaceutical interventions, not dietary supplements.
Sleep is another area where the data looks surprisingly pharmaceutical. A systematic review and meta-analysis pooling multiple randomized trials found that ashwagandha improved sleep quality, shortened the time it takes to fall asleep, increased total sleep time, reduced nighttime wakefulness, and boosted sleep efficiency compared to placebo.5PLOS ONE. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis A separate double-blind trial that tested the extract in both healthy volunteers and people with insomnia confirmed that sleep onset latency and sleep efficiency were the parameters that improved the most.6PubMed. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients You fall asleep faster, stay asleep longer, and spend a greater proportion of your time in bed actually sleeping. That is functionally what a sleep drug is supposed to do.
Hormonal Effects That Most Users Don’t Expect
If ashwagandha only affected mood and sleep, calling it drug-like would be a stretch. But it also moves the needle on thyroid hormones and reproductive hormones, and those effects carry real consequences people should know about before they start taking it.
In a double-blind trial of people with mildly underactive thyroids, eight weeks of ashwagandha root extract significantly improved TSH, T3, and T4 levels compared to placebo, effectively normalizing thyroid function over the treatment period.7PubMed. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients A broader review confirmed this pattern: ashwagandha appears to elevate thyroid hormones in people with low thyroid function.8PubMed Central. Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)
The problem is that this same thyroid-stimulating effect can overshoot. A case report documented a 73-year-old woman who self-treated her hypothyroidism with ashwagandha for two years and developed thyrotoxicosis, presenting with a dangerously fast heart rate, symptoms of hyperthyroidism, and very low TSH. Her symptoms resolved after she stopped taking the supplement.9PubMed Central. Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting With Supraventricular Tachycardia Anyone already taking thyroid medication should treat ashwagandha the same way they would treat an additional thyroid drug, because that is essentially what it is doing.
On the reproductive side, a pilot study in men with low sperm counts found that 90 days of ashwagandha root extract produced a 167% increase in sperm concentration, a 53% increase in semen volume, and a 57% improvement in sperm motility. Serum testosterone rose about 17%, and luteinizing hormone increased about 34%.10PubMed Central. Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha (Withania somnifera) in Oligospermic Males Those changes are striking enough that reviews have discussed ashwagandha in the context of managing male infertility, noting improvements in sperm parameters and reproductive hormone regulation across studies.11PubMed. Role of Withania somnifera (Ashwagandha) in the management of male infertility
Physical Performance and Metabolic Effects
Ashwagandha has earned a following in fitness communities, and the research gives some justification for that. A meta-analysis of athletic performance studies found that ashwagandha improved VO2max by about 4 ml/min/kg compared to placebo, a meaningful boost in aerobic capacity.12Turkish Journal of Sports Medicine. The effect of Ashwagandha (Withania somnifera) on sports performance: a systematic review and meta-analysis An eight-week trial in people doing resistance training showed a roughly 9.5% increase in VO2max in men and a 7% increase in women taking a standardized root extract, compared to placebo.13PubMed Central. Effects of Ashwagandha (Withania somnifera) standardized root extract on physical endurance and VO2max in healthy adults performing resistance training
There is also emerging evidence around blood sugar regulation. Reviews of the preclinical and clinical data suggest ashwagandha’s active compounds affect multiple steps in glucose metabolism: inhibiting enzymes involved in carbohydrate breakdown, boosting insulin secretion from the pancreas, and improving insulin sensitivity in peripheral tissues.14PubMed Central. Ashwagandha (Withania somnifera) in insulin resistance and metabolic syndrome Systematic reviews indicate it can improve blood glucose and HbA1c levels without major safety concerns, though the clinical trial base is still small.15PubMed. Unveilling the antidiabetic potential of ashwagandha (Withania somnifera L.) and its withanolides In a mouse model of type 2 diabetes, ashwagandha treatment reduced systemic inflammation, improved glucose tolerance and insulin sensitivity, and restored pancreatic beta-cell function.16PubMed. Anti-inflammatory and anti-diabetic role of Ashwagandha (Withania somnifera) in a type 2 diabetes mellitus mouse model If you are on diabetes medication, adding ashwagandha could compound the blood-sugar-lowering effect in ways your prescriber hasn’t accounted for.
When Something Goes Wrong
The liver injury reports are probably the most sobering evidence that ashwagandha acts like a drug. Cases of liver damage linked to ashwagandha supplements have surfaced from Japan, Iceland, India, and the United States.17PubMed Central. Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury A case series pulled together five patients from Iceland and the U.S. Drug-Induced Liver Injury Network. All five developed jaundice along with nausea, fatigue, itching, and abdominal discomfort after two to twelve weeks of use. The liver injury was cholestatic or mixed. The itching and elevated bilirubin lingered for 5 to 20 weeks in some patients. Chemical analysis of the supplements confirmed ashwagandha was present and identified no other toxic contaminants.18PubMed Central. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network
Five cases does not make ashwagandha broadly hepatotoxic, and millions of people take it without liver problems. But the pattern is consistent with how drug-induced liver injury works: a small fraction of users with individual susceptibility develop a reaction that can be serious. This is the same phenomenon seen with prescription medications like antibiotics or anti-epileptics, and it underscores that ashwagandha is not pharmacologically inert just because it grows in the ground.
It Interacts With Drugs the Way Other Drugs Do
Any substance that modifies the cytochrome P450 enzyme system has the potential to change how your body handles prescription medications, and ashwagandha touches this system. One study found that a 70% ethanol ashwagandha root extract modulated CYP3A4, one of the most important drug-metabolizing enzymes in the human liver. CYP3A4 processes a large share of commonly prescribed drugs, including statins, immunosuppressants, and certain blood thinners. Altering its activity can either reduce the effectiveness of a drug or increase its concentration to toxic levels.19PubMed Central. Ashwagandha (Withania somnifera) Plant Extracts Affect the Cytochrome P450 System and Cytotoxicity of Primary Human Hepatocytes
The picture is complicated, though, because different extracts behave differently. A separate study testing four different ashwagandha root and leaf extracts against seven major P450 enzymes found no reversible inhibition at relevant concentrations.20PubMed Central. Evaluation of reversible cytochrome P450 inhibition by Withania somnifera leaf and root extracts The discrepancy likely comes down to the extraction method and the specific chemical profile of each product. This is a practical headache for consumers: whether your particular supplement interacts with your particular medication depends on variables you cannot see on the label. This kind of product-to-product variability in pharmacological action is unusual for supplements but entirely typical for drugs.
Withdrawal Symptoms Suggest Real Dependence Potential
Perhaps the clearest signal that ashwagandha acts on the brain like a drug is what happens when some people stop taking it. A published case report documented a patient who experienced symptoms consistent with withdrawal after stopping ashwagandha, potentially mediated by its GABAergic activity. The timing and severity of symptoms after discontinuation suggested a withdrawal phenomenon rather than just a return of underlying anxiety, though the authors acknowledged that distinguishing between the two is difficult.21PubMed Central. Unmasking Potential Withdrawal Effects of Ashwagandha: A Case Report and Review
This makes pharmacological sense. Substances that act on GABA receptors, from alcohol to benzodiazepines, can produce rebound anxiety and insomnia when stopped abruptly, especially after prolonged use. If ashwagandha is activating the same receptor family to a meaningful degree, some degree of neuroadaptation and withdrawal is biologically plausible. The evidence here is still limited to case-level data, not controlled trials, but it reinforces the argument that treating this supplement casually may be a mistake.
What’s Actually in the Bottle Varies Enormously
With a pharmaceutical drug, the active ingredient is standardized to a precise amount and the manufacturing process is regulated. With ashwagandha supplements, neither is guaranteed, and the variation between products is staggering.
A crossover bioavailability study comparing four different ashwagandha extracts in healthy adults illustrated the problem. The extract with the highest withanolide concentration (35% withanolide glycosides) had an overall bioavailability more than 267 times greater than the lowest-concentration extract, along with a significantly higher peak blood level, longer half-life, and extended time in the body.22Current Therapeutic Research. Randomized, Double-Blind, Crossover Study Comparing the Bioavailability of 4 Ashwagandha (Withania somnifera (L.) Dunal) Extracts in Healthy Adults Under Fasting Condition A second pharmacokinetic study confirmed these differences, finding the higher-concentration extract to be roughly 280 times more bioavailable than the lower-concentration one on a per-milligram basis.23PubMed Central. Pharmacokinetics and bioequivalence of Withania somnifera (Ashwagandha) extracts A newer formulation at just 1.5% withanolide content achieved over twice the bioavailability of a 5% extract at a higher dose, through a different delivery technology.24PubMed Central. Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™)
What this means in practice: two people both taking “600 mg of ashwagandha” could be getting wildly different pharmacological exposures depending on which brand they bought. There is no equivalent of this in the drug world, where 10 mg of atorvastatin means 10 mg of atorvastatin regardless of manufacturer.
Contamination adds another layer. A study of adaptogenic herbal supplements found that lead concentrations in processed forms like tablets exceeded permissible limits by up to 235%, while nickel exceeded limits by up to 321%.25PubMed Central. Heavy Metal Contamination in Adaptogenic Herbal Dietary Supplements Research on medicinal plants from northwestern India found that ashwagandha samples collected near industrial areas contained chromium above the WHO’s permissible limit for raw herbal material.26PubMed Central. Investigation of heavy metals in frequently utilized medicinal plants collected from environmentally diverse locations of north western India You are taking a pharmacologically active product, and depending on where and how it was produced, you might also be taking heavy metals along with it.
European Regulators Are Starting to Treat It Like a Drug
The regulatory response to ashwagandha is catching up to its pharmacology, at least in parts of the world. In the European Union, increasing scrutiny over its safety profile has led to a recommendation for a formal procedure under food-supplement regulations that could ultimately ban its use as a supplement ingredient.27Wiley Online Library. Ashwagandha: Is It Safe? Part 1: A Regulatory Review In the United States, ashwagandha remains freely sold as a dietary supplement under the relatively permissive framework that governs the supplement industry, requiring no proof of efficacy or premarket safety review.
This regulatory gap is exactly the problem. A substance that modulates GABA receptors, shifts thyroid hormone levels, affects reproductive hormones, alters drug-metabolizing enzymes, and has caused liver injury in multiple countries would face rigorous premarket evaluation if it were introduced as a new pharmaceutical. Because it arrived through the supplement door, it skips all of that. The EU’s move toward restriction reflects a growing recognition that the supplement label does not match the pharmacological reality.
The Immune System Gets Pushed in Two Directions
Ashwagandha’s immune effects add yet another dimension to its drug-like profile, and they are surprisingly complex. At a cellular level, an ashwagandha-based formulation significantly suppressed pro-inflammatory molecules including TNF-alpha, IL-1 beta, and MIP-1 alpha in mouse immune cells, suggesting anti-inflammatory properties that could be relevant for conditions driven by chronic inflammation.28PubMed Central. Effect of a Novel Ashwagandha-based Herbomineral Formulation on Pro-inflammatory Cytokines Expression in Mouse Splenocyte Cells
But ashwagandha also stimulates certain arms of the immune system. A leaf extract given orally to mice boosted T-cell activity and increased production of interferon-gamma, a cytokine central to the body’s defense against viruses and intracellular pathogens, while moderately suppressing IL-4, a cytokine associated with a different branch of immunity.29PubMed. Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity This dual capacity, dampening some immune pathways while stimulating others, is a hallmark of immunomodulatory drugs. It is a very different profile from, say, vitamin C, which has modest and nonspecific effects. For people with autoimmune conditions or those on immunosuppressive therapy, this kind of immune-shaping activity is not something to experiment with casually.
Why People Prefer It Over Pharmaceuticals
Despite the pharmacological complexity, consumer psychology pulls strongly toward ashwagandha and similar natural products, especially for mental health. Research in consumer behavior has found that people have a general preference for natural medicines over synthetic ones, but that preference becomes significantly stronger when the condition being treated is psychological rather than physical. The driving factor is concern about identity: people worry more that synthetic drugs will alter their “true self” and perceive natural remedies as less likely to do so.30Journal of Consumer Psychology. Consumers prefer natural medicines more when treating psychological than physical conditions
The irony is worth sitting with. Ashwagandha’s anti-anxiety and sleep effects come from activating the same brain receptors that benzodiazepines target. Its calming properties are mediated by the same HPA axis suppression that pharmaceutical anxiolytics aim for. The mechanism does not become gentler because the molecule grew in soil instead of being synthesized in a lab. Perceiving ashwagandha as fundamentally different from a drug because it is “natural” is a psychological bias, not a pharmacological one. This does not mean people should avoid it, but it does mean they should approach it with the same respect for dosing, interactions, and side effects that they would bring to any prescription affecting their brain chemistry, hormones, and liver.
Neuroprotection and the BDNF Connection
One area where ashwagandha research is particularly intriguing, though still mostly preclinical, is its potential to protect brain cells and promote neuroplasticity. An animal study found that ashwagandha leaf extract counteracted drug-induced declines in brain-derived neurotrophic factor (BDNF), a protein critical for the growth and maintenance of neurons. At higher doses, the extract not only prevented the decline but substantially boosted BDNF expression above baseline levels, suggesting it contains factors that could enhance the brain’s capacity for plasticity and repair.31PLoS ONE. Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells BDNF is one of the molecules that pharmaceutical antidepressants are thought to work through, which adds another parallel between ashwagandha and conventional drugs. The big caveat is that boosting BDNF in mouse brains does not automatically translate to cognitive benefits in humans; that gap between animal findings and clinical proof remains wide for many promising compounds.
Ashwagandha’s long history in Ayurvedic medicine, where it has been classified as a “rasayana” or rejuvenating tonic for centuries, aligns with these neuroprotective findings at least thematically.32PubMed Central. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda Traditional texts describe it being used for nervous disorders, general weakness, and cognitive decline, applications that modern research has begun to test rather than simply debunk.33PubMed. Rational use of Ashwagandha in Ayurveda (Traditional Indian Medicine) for health and healing The traditional uses do not prove efficacy, but they do represent centuries of observational data that pointed researchers toward biological pathways that turned out to be real.